Bruce & Co., Inc.
- SEC CIK
- 0001358331
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 15, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 37
- +3 vs. Q3 2022
- Portfolio value
- $387.9M
- +$24.0M (+6.6%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UHAL.BU-Haul Holding Co | COM SER N | 660,530 | $36.3M | 9.4% | +660,530 | New | History |
| MRKMerck & Co., Inc. | COM | 302,700 | $33.6M | 8.7% | −21,000−6.5% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 202,500 | $32.7M | 8.4% | −21,000−9.4% | Reduced | History |
| FPL Group Inc302571104 | COM | 347,500 | $29.1M | 7.5% | −2,500−0.7% | Reduced | – |
| PFEPfizer Inc | Stock | 542,700 | $27.8M | 7.2% | 00.0% | Unchanged | History |
| DUKDuke Energy CORP | Stock | 261,200 | $26.9M | 6.9% | 00.0% | Unchanged | History |
| CMSCMS Energy Corp | COM | 418,500 | $26.5M | 6.8% | 00.0% | Unchanged | History |
| XELXcel Energy Inc | Stock | 372,500 | $26.1M | 6.7% | 00.0% | Unchanged | History |
| ALLAllstate Corp | Stock | 178,300 | $24.2M | 6.2% | −51,000−22.2% | Reduced | History |
| TAT&T Inc. | Stock | 1,132,000 | $20.8M | 5.4% | +60,000+5.6% | Added | History |
| ABTAbbott Laboratories | Stock | 167,600 | $18.4M | 4.7% | 00.0% | Unchanged | History |
| Paratek699374AA2 | Cv 4.75% | – | $14.4M | 3.7% | – | – | – |
| AVAAvista Corp | COM | 205,000 | $9.09M | 2.3% | 00.0% | Unchanged | History |
| AAPLApple Inc. | Stock | 64,500 | $8.38M | 2.2% | −1,500−2.3% | Reduced | History |
| IIINInsteel Industries Inc | COM | 274,000 | $7.54M | 1.9% | 00.0% | Unchanged | History |
| FOCLEdap TMS SA | SPONSORED ADR | 565,652 | $6.03M | 1.6% | 00.0% | Unchanged | History |
| Bausch Health91911K102 | Common | 931,000 | $5.85M | 1.5% | 00.0% | Unchanged | – |
| UHALU-Haul Holding Co | COM | 75,055 | $4.52M | 1.2% | −400−0.5% | Reduced | History |
| SIRISirius XM Holdings Inc. | COM | 657,843 | $3.84M | 1.0% | 00.0% | Unchanged | History |
| Acorda Theraputics00484MAB2 | Cv 6.0% | – | $3.75M | 1.0% | – | – | – |
| SUPNSupernus Pharmaceuticals, Inc. | COM | 92,105 | $3.29M | 0.8% | −30,000−24.6% | Reduced | History |
| NEMNEWMONT Corp | Stock | 65,000 | $3.07M | 0.8% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,557,312 | $2.91M | 0.8% | 00.0% | Unchanged | History |
| Accelerate Diagnostics, Inc00430HAB8 | NOTE 2.500% 3/1 | – | $2.76M | 0.7% | – | – | – |
| Amryt Pharma PLC03217L106 | SPONSORED ADS | 315,182 | $2.30M | 0.6% | 00.0% | Unchanged | – |
| ASHAshland Inc. | COM | 15,000 | $1.61M | 0.4% | −10,000−40.0% | Reduced | History |
| MNKDMannkind Corp | COM NEW | 195,073 | $1.03M | 0.3% | 00.0% | Unchanged | History |
| IGMSIGM Biosciences, Inc. | COM | 55,000 | $935.5K | 0.2% | 00.0% | Unchanged | History |
| OGNOrganon & Co. | Stock | 31,470 | $879.0K | 0.2% | −500−1.6% | Reduced | History |
| VTRSViatris Inc | Stock | 60,272 | $670.8K | 0.2% | −1,240−2.0% | Reduced | History |
| Novavax Inc670002AB0 | NOTE 3.750% 2/0 | – | $590.0K | 0.2% | – | – | – |
| FATEFate Therapeutics Inc | COM | 57,000 | $575.1K | 0.1% | 00.0% | Unchanged | History |
| MASS908 Devices Inc. | COM | 68,286 | $520.3K | 0.1% | +68,286 | New | History |
| LVTXLAVA Therapeutics NV | SHS | 100,000 | $350.0K | 0.1% | +100,000 | New | History |
| RLIRli Corp | COM | 2,400 | $315.0K | 0.1% | 00.0% | Unchanged | History |
| WBDWarner Bros. Discovery, Inc. | Stock | 14,510 | $137.6K | <0.1% | −108,048−88.2% | Reduced | History |
| PSNLPersonalis, Inc. | COM | 50,000 | $99.0K | <0.1% | +50,000 | New | History |
Sold out since Q3 2022 (1)
Positions held at the end of Q3 2022 that are gone from this filing.